Dr. Trevor P. Castor, PhD
Founder, President and Chief Executive Officer
Dr. Trevor P. Castor is President and CEO of Aphios Corporation and subsidiaries including Aphios Pharma LLC, North Reading, MA. He has over 35 years of diversified experience in technology and business development, management, marketing and finance in the pharmaceutical and biotechnology industries. He graduated from the University of California, Berkeley with a Ph.D. in Mechanical Engineering and a MSc in Chemical Engineering, and a BSc in Chemical Engineering summa cum laude from the University of Toronto, Canada. He studied Business Administration at St. Mary’s College, Brooklyn, NY, and Harvard University Extension Program, Cambridge, MA. He is the author of 86 issued and 43 pending patents on nanotechnology drug delivery and other enabling technology platforms, and enhanced therapeutic products as well as several peer-reviewed publications. His research has been funded by competitive NIH, NSF and NIST grants, and he has been an ad hoc NIH reviewer for more than two decades. He has collaborated with several multinational pharmaceutical companies including Eli Lilly, BMS, Novartis, Pfizer and Merck-Millipore-Sigma, and financial institutions such as the Bank of New England, the New England Life Insurance Company and the United Nations.
Dr. Christopher D. Breder, MD, PhD
Fractional Chief Medical Officer | Member, Board of Directors | Scientific Advisory Board
Dr. Christopher D. Breder is a highly accomplished physician-scientist with over 20 years of leadership experience spanning the U.S. Food and Drug Administration and the global biopharmaceutical industry. He brings deep expertise in clinical development, regulatory strategy, and safety assessment across a broad range of therapeutic areas, including neurology, anesthesiology, and rare diseases. At the FDA, Dr. Breder served as Medical Officer and Lead Medical Officer, where he oversaw more than 500 Investigational New Drug (IND) applications and contributed to multiple New Drug Application (NDA) and Biologics License Application (BLA) approvals. His work included key roles in regulatory decision-making, safety evaluation, and cross-disciplinary leadership on complex drug development programs. In industry, Dr. Breder held senior clinical development leadership roles at Bristol Myers Squibb, Supernus Pharmaceuticals, and Sunovion Pharmaceuticals. He has successfully built and led clinical development organizations, designed and executed global clinical programs, and advanced multiple therapeutic candidates from early-stage development through regulatory approval and lifecycle management. Dr. Breder has advised biotechnology companies, investors, and legal teams on clinical strategy, regulatory pathways, due diligence, and risk assessment. His unique dual perspective—combining regulatory insight with industry execution—positions him as a trusted advisor in advancing innovative therapeutics efficiently and strategically. At Aphios, Dr. Breder provides executive leadership in clinical development and regulatory strategy, supporting the advancement of the Company’s pipeline and enhancing its ability to achieve key value inflection points.
Dr. Val R. Livada, PhD
Member, Board of Directors
Dr. Val R. Livada is Founder and CEO of Weybridge Partners, Acton, MA, which is focused on successful technology commercialization. Dr. Livada was a Senior Lecturer (retired) on Corporate Entrepreneurship at the Sloan School of Management, MIT, Cambridge, MA. He has over 30 years of experience in the areas of strategic planning and organizational dynamics with detailed knowledge in the areas of innovation, product development and R&D management. Dr. Livada’s clients have included Fortune 500 companies such as GM and Eli Lilly. He received his undergraduate degree from MIT, and his M.A. and Ph.D. from Tufts University, Boston, MA.
Dr. Juliette M. Tuakli, MD, MPH
Member, Board of Directors
Dr. Juliette M. Tuakli is an accomplished physician-leader, healthcare entrepreneur and international board director with over 30 years of experience in clinical medicine, public health, healthcare systems, corporate governance and global development. She currently serves as an Independent Non-Executive Director of Zenith Bank Ghana, where she has chaired the Finance and General Purpose, Governance, and Remuneration Committees and serves on the Audit and Governance Committees. She previously served as Chair of the International Board of Trustees of United Way Worldwide, an international network of approximately 1,800 affiliates across 40 countries. Dr. Tuakli founded and led Family Child & Associates in Accra, Ghana, growing the organization from a pediatric practice into a major maternal and child healthcare provider serving more than 6,000 patients. Her career has included leadership, faculty, board and advisory roles with Boston Children’s Hospital, Harvard School of Public Health, Mercy Ships International, the World Health Organization, the Commonwealth Human Rights Initiative, CarePoint and the Global Virus Network. Dr. Tuakli holds a BSc from the University of Zambia, an MD from the University of London and an MPH from the University of California, Los Angeles. At Aphios, she brings extensive experience in healthcare, governance, organizational leadership and international partnerships to support the Company’s strategic growth and global development.